Medication info

Colesnon 40mg (Simvastatin)

Prescription medicationTabletOralExpired
Ingredient · strength
Simvastatin›40mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
It is an oval-shaped film-coated tablet with a pale rose color.
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200400165 · Notified 2004.02.03

This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) See the information below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the medicine must not be used under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular disease in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke. Specifically, it reduces the risks of death from coronary heart disease, non-fatal myocardial infarction, stroke, and vascular interventions. It is also used to lower total cholesterol, LDL cholesterol, Apo-B proteins, and triglyceride levels while increasing HDL cholesterol levels in patients with primary hyperlipidemia and dyslipidemia. This drug is effective in patients with mixed dyslipidemia and type III and IV dyslipidemia, as well as in patients with homozygous familial hypercholesterolemia. For pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet certain criteria, it is used as an adjunct to diet to reduce total cholesterol and LDL cholesterol levels. This medication effectively improves cardiovascular health and treats hyperlipidemia.

How to take

Adult dose

Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) See the information below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the medicine must not be used under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day.

Precautions

This medication is primarily used to lower cholesterol levels. Muscle-related issues may occur during treatment, especially when taking high doses or concomitant medications, increasing the risk of serious muscle damage known as myopathy or rhabdomyolysis. Therefore, patients taking this medication at high doses should immediately inform their doctor if they experience muscle pain or weakness, and dosage adjustments or a switch to another medication may be necessary. This drug is not to be administered to patients with poor liver function or active liver disease. Moreover, women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Co-administration with potent CYP3A4 inhibitors, certain lipid-lowering medications, some antibiotics, and other drugs may elevate the risk of muscle damage; hence, consultation with a physician is essential. Special precautions are necessary for the elderly, patients with impaired kidney function, or those with hypothyroidism. Regular liver function tests and muscle-related examinations during treatment are recommended, and it is crucial to notify medical staff of any abnormal symptoms. Additionally, specific foods like grapefruit juice may increase the plasma concentration of this medication and raise the risk of side effects, so they should be avoided. The use of this medication in children and adolescents is limited because it can affect growth and development, and it should be taken under the guidance of a specialist. In case of overdose, prompt medical attention should be sought, and this medication should be stored out of reach of children.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 78 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • immune-mediated necrotizing myopathy
  • specific cranial nerve dysfunction
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • psychiatric disorders
  • anxiety
  • sleep disturbances
  • depression
  • cognitive impairment
  • myasthenia gravis
  • oculomotor weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • increased aminotransferases
  • elevated ALP
  • increased γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • diabetes
  • pancreatitis
  • loss of appetite
  • vomiting
  • thrombocytopenia
  • lupus-like syndrome
  • vasculitis
  • purpura
  • thrombocytopenic
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • interstitial lung disease
  • sensory numbness in the extremities
  • paresthesia
  • cold sensation
  • sensory impairment
  • muscle weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and ensure safe use.

Appearance and packaging

Appearance

It is an oval-shaped film-coated tablet with a pale rose color.

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.